-
Product Insights
NewViral Conjunctivitis – Drugs In Development, 2024
Empower your strategies with our Viral Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Viral conjunctivitis, or pinkeye, is a common, self-limiting condition that is typically caused by adenovirus. Viral conjunctivitis is highly contagious, usually for 10–12 days from onset as long as the eyes are red. Symptoms include itchy eyes, tearing, redness, discharge, and light sensitivity (with corneal involvement). Treatment includes lubricants, vasoconstrictors, and antihistamines. The Viral Conjunctivitis drugs in development market research report provide...
-
Product Insights
NewCataract – Drugs In Development, 2024
Empower your strategies with our Cataract – Drugs In Development, 2024 report and make more profitable business decisions. A cataract is a clouding of the normally clear lens of eye that affects vision. Symptoms include clouded, blurred, or dim vision; increasing difficulty with vision at night; fading or yellowing of colors; double vision in a single eye; and frequent prescription changes in eye wear. Risk factors include age, diabetes, excessive alcohol consumption, high blood pressure, obesity, and smoking. The Cataract drugs...
-
Product Insights
NewPresbyopia – Drugs In Development, 2024
Empower your strategies with our Presbyopia – Drugs In Development, 2024 report and make more profitable business decisions. Presbyopia is an eye condition in which the eyes slowly lose the ability to focus quickly on objects that are close. Presbyopia happens in people as they age. Signs and symptoms include headaches, eye strain, difficulty reading small print, and fatigue. Risk factors include anemia, diabetes, cardiovascular disease, hyperopia, multiple sclerosis, myasthenia gravis, and eye trauma. The Presbyopia drugs in development market research...
-
Product Insights
NewNeurofibromatoses Type II – Drugs In Development, 2024
Empower your strategies with our Neurofibromatoses Type II – Drugs In Development, 2024 report and make more profitable business decisions. Neurofibromatosis type 2 is a disorder characterized by the growth of noncancerous tumors in the nervous system. These growths develop along the nerve that carries information from the inner ear to the brain (the auditory nerve). Tumors that occur on other nerves are also commonly found with this condition. The signs and symptom are hearing loss, ringing in the ears (tinnitus),...
-
Product Insights
NewNeurofibromatoses – Drugs In Development, 2024
Empower your strategies with our Neurofibromatoses – Drugs In Development, 2024 report and make more profitable business decisions. Neurofibromatosis (NF) is a term for a group of genetic disorders that cause benign tumors to grow on nerve tissue. There are three types of NF: NF1, NF2, and schwannomatosis. Each type has different signs and symptoms, such as skin spots, freckles, bumps, hearing loss, vision loss, pain, and bone deformities. NF is caused by mutations in certain genes that regulate nerve cell...
-
Product Insights
NewWest Nile Virus Infections – Drugs In Development, 2024
Empower your strategies with our West Nile Virus Infections – Drugs In Development, 2024 report and make more profitable business decisions. West Nile infection is caused by a virus transmitted by mosquitoes. The West Nile virus is a type of virus known as a Flavivirus. Symptoms include a fever, headache, body aches, skin rash, and swollen lymph glands. Risk factors for developing a more severe form of West Nile virus include conditions that weaken the immune system, such as HIV, organ...
-
Product Insights
NewMyopia – Drugs In Development, 2024
Empower your strategies with our Myopia – Drugs In Development, 2024 report and make more profitable business decisions. Myopia, a form of nearsightedness, is a ophthalmological disorder that results in blurred vision when looking at distant objects. This occurs due to the improper refraction of light in the eye, causing the focal point to fall in front of the retina, rather than on it. Close-up objects can still be seen clearly. The underlying cause of myopia can be attributed to specific...
-
Product Insights
NewConjunctivitis – Drugs In Development, 2024
Empower your strategies with our Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Conjunctivitis, commonly known as "pink eye", refers to inflammation of the conjunctiva, the thin, transparent layer covering the white part of the eye and the inner surface of the eyelids. This condition can be caused by various factors, including infections, allergies, or irritants. Viral conjunctivitis is typically caused by viruses associated with the common cold; it is highly contagious and often spreads through...
-
Product Insights
NewDengue Fever – Drugs In Development, 2024
Empower your strategies with our Dengue Fever – Drugs In Development, 2024 report and make more profitable business decisions. Dengue is a mosquito-borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from the nose, gums, or under the skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of...